Markedsdata leveret af TwelveData og Morningstar
Biotechnology Assets, S.A. is a biotechnology company focused on developing, producing, and commercializing biological solutions for pharmaceutical, healthcare, animal health, agricultural, cosmetic, and chemical applications. Its portfolio includes SPLITTERA, a platform designed for site-specific protein conjugation; Click Car, which provides universal connectors for Split-CAR applications; VACC-ZERA, a tool for producing recombinant proteins in microparticles; and CLICK’N CUT, a technology for tag-free protein purification. The company also works with active therapeutic substances, recombinant proteins, vaccines, probiotics, feed additives, and other specialized biotechnological products. Biotechnology Assets, S.A. serves organizations involved in biopharmaceutical research, drug development, veterinary care, agriculture, and industrial biotechnology, while supporting the development, transfer, licensing, and commercialization of intellectual property. Headquartered in Jerez de la Frontera, Spain, the company occupies a specialized position in the biotechnology market by connecting research capabilities with practical platforms for protein engineering, biomanufacturing, and health-related applications.